Tissue Engineering Research Group, Division of Molecular Therapy, The Institute of Medical Science, The University of Tokyo

Welcome to the Tissue Engineering Research Group, Division of Molecular Therapy.

The purpose of our group is to develop and establish new technologies in the field of regenerative medicine such as alveolar bone tissue engineering. Through research that ranges from basic science to clinical studies, we are committed to providing more effective therapies that can reduce the burden for patients who currently do not have appropriate treatment.

• Clinical Studies in Progress
• Completed Clinical Studies

• 2010/03/15The clinical study on bone tissue engineering has been approved by the Ministry of Health, Labour and Welfare of Japan.

• 2010/02/02The clinical study on bone tissue engineering has been approved by the Committee of Ministry of Health, Labour and Welfare of Japan.

• 2010/12/07Scientific PapersKagami H, Agata H, Tojo A. Bone marrow stromal cells (bone marrow-derived multipotent mesenchymal stromal cells) for bone tissue engineering: Basic science to clinical translation. Int J Biochem Cell Biol. 2010 Dec 13. [Epub ahead of print] PMID: 21147252